脂肪酸結(jié)合蛋白 4(FABP4)多克隆抗體
Polyclonal Antibody to Fatty Acid Binding Protein 4 (FABP4)
A-FABP; AFABP; AP2; Fatty Acid Binding Protein 4, Adipocyte; Adipocyte Protein 2; Adipocyte-type fatty acid-binding protein
- 編號(hào)PAB693Hu06
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來(lái)源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無(wú)標(biāo)記物
- 免疫原 EPB693Hu61-脂肪酸結(jié)合蛋白 4(FABP4)真核蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4, 含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀液體
- 濃度500μg/mL
- 且適物種Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠), Sus scrofa; Porcine (Pig，豬)
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見(jiàn)流式抗體。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 598 ¥ 1394 ¥ 1992 ¥ 4980 ¥ 19920
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
WB圖
-
Western Blot; Samples: Lane1: Rat Heart lysate; Lane2: Mouse Heart lysate; Lane3: Porcine Heart lysate; Lane4: 293F cell lysate; Lane5: C2C12 cell lysate;
Primary Ab: 0.2μg/ml Rabbit Anti-Human FABP4 Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)FABP4的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別FABP4。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| EPB693Hu61 | 脂肪酸結(jié)合蛋白 4(FABP4)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPB693Hu62 | 脂肪酸結(jié)合蛋白 4(FABP4)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB693Hu01 | 脂肪酸結(jié)合蛋白 4(FABP4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB693Hu61 | 脂肪酸結(jié)合蛋白 4(FABP4)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAB693Hu06 | 脂肪酸結(jié)合蛋白 4(FABP4)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB693Hu01 | 脂肪酸結(jié)合蛋白 4(FABP4)多克隆抗體 | WB; IHC; ICC; IP. |
| FAB693Hu01 | 抗脂肪酸結(jié)合蛋白 4(FABP4)多克隆抗體 | Flow cytometry. |
| LAB693Hu71 | 脂肪酸結(jié)合蛋白 4(FABP4)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAB693Hu21 | 脂肪酸結(jié)合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu23 | 脂肪酸結(jié)合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu24 | 脂肪酸結(jié)合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu25 | 脂肪酸結(jié)合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu27 | 脂肪酸結(jié)合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu29 | 脂肪酸結(jié)合蛋白 4(FABP4)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB693Hu22 | 脂肪酸結(jié)合蛋白 4(FABP4)單克隆抗體 | WB; IHC. |
| FAB693Hu02 | 抗脂肪酸結(jié)合蛋白 4(FABP4)單克隆抗體 | Flow cytometry. |
| FAB693Hu06 | 抗脂肪酸結(jié)合蛋白 4(FABP4)單克隆抗體 | Flow cytometry. |
| FAB693Hu04 | 抗脂肪酸結(jié)合蛋白 4(FABP4)單克隆抗體 | FCM |
| SEB693Hu | 脂肪酸結(jié)合蛋白 4(FABP4)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB693Hu | 脂肪酸結(jié)合蛋白 4(FABP4)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Clinical and Molecular Hepatology | Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH [PubMed: 23091808] |
| journal of Human Hypertension | Siesta is associated with reduced systolic blood pressure level and decreased prevalence of hypertension in older adults [PubMed: 26134622] |
| genetics and molecular research | Overexpression of the A-FABP gene facilitates intermuscular fat deposition in transgenic mice [PubMed: 25867423] |
| Food Chem | Cranberries (Oxycoccus quadripetalus) inhibit lipid metabolism and modulate leptin and adiponectin secretion in 3T3-L1 adipocytes [PubMed: 25952883] |
| Placenta | Increased expression of fatty acid binding protein 4 in preeclamptic Placenta and its relevance to preeclampsia [Pubmed:26992681] |
| Clin Chim Acta. | Valproate acid (VPA)-induced dysmetabolic function in clinical and animal studies. [pubmed:28161274] |
| Oxidative?Medicine?and?Cellular?Longevity | Changes of Plasma FABP4, CRP, Leptin, and Chemerin Levels in relation to Different Dietary Patterns and Duodenal-Jejunal Omega Switch Surgery in Sprague?… [Pubmed:29849871] |
| Nutrition &?Diabetes | Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans [Pubmed:29335416] |
| American Journal of Cancer Research | 25-HC promotes hepatocellular carcinoma metastasis through up-regulation of TLR4 dependent FABP4 [Pubmed: 31720079] |
| J Magn Reson Imaging | Water Specific MRI T1 Mapping for Evaluating Liver Inflammation Activity Grades in Rats With Methionine‐Choline‐Deficient Diet‐Induced Nonalcoholic Fatty Liver?… [Pubmed:35212074] |
| cells | The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure [Pubmed:35455943] |
| Bone Research | FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis to exacerbate rheumatoid arthritis [Pubmed:35729106] |
